Biochemistry
9th Edition
ISBN: 9781319114671
Author: Lubert Stryer, Jeremy M. Berg, John L. Tymoczko, Gregory J. Gatto Jr.
Publisher: W. H. Freeman
expand_more
expand_more
format_list_bulleted
Question
- Large animals should have higher lifetime probabilities of cancer than small animals because each cell division carries a risk of mutating towards a tumor lineage, and large animals have many more cells. However, this is not observed—a paradox that suggests large and/or long-lived species tend to evolve effective cancer suppression mechanisms. Based on the principle of allocation, the evolutionary value of cancer suppression should be determined by the ‘cost’ of suppression (decreased fecundity) vs. the ‘cost’ of cancer (reduced survivorship). Should effective cancer suppression be more common in more r-selected (fast life history) or K-selected (slow life history) species? Explain your reasoning.
The formula list is attached.
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution
Trending nowThis is a popular solution!
Step by stepSolved in 3 steps
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biochemistry and related others by exploring similar questions and additional content below.Similar questions
- during tumor progression, additional mutations occur within multiple cells of a tumor population, leading to multiple different clones of cells within that tumor. Some) but not all) clones may eventually metastasize, depending on the number and type of mutations that occur in those clones. true falsearrow_forwardLong non-coding RNAs (lncRNA) can act as a scaffold to form protein/RNA complexes that regulate gene expression? True False Wnt is a regulatory factor that regulate myogenic stem cell proliferation? True Falsearrow_forwardThe deregulation of several signal transduction pathways is integral to the onset of cancer. These pathways involve both tumor promoters (the "gas pedals") and tumor suppressors (the "brake pedals"). Which would be a more effective treatment for cancer: A small molecule inhibitor that targets a tumor suppressor or one that targets a tumor promoter? Briefly explain your choice. (THIS CAN BE DONE IN LESS THAN TWO SENTENCES, AND MINIMALLY IN ABOUT EIGHT WORDS.) Edit View. Insert Format Tools Table 12pt v Paragraph BI UAV 2VT² V| :arrow_forward
- Every year, about a million Americans are diagnosed with cancer. This means that about 75 million Americans now living will eventually have cancer, And one in five will die of the disease. There are many kinds of cancers and many causes, such as smoking, overexposure to ultraviolet rays, a high fat and low fiber diet, and some workplace chemicals. Hundreds of millions of dollars are spent each year on searching for treatment, yet less money is spent on prevention. Should we devote more resources to treating cancer or to preventing it? Explain.arrow_forwardHow would you expect the mitotic index of a cancer tissue to compare with that of the onion root tip?arrow_forwardWith regard to human cancer cells, which of the following statements is true? A. Cancer cells within one tumor usually do not share common mutations B. Cancer cells generally have lost the ability to divide C. Oncogenes are non-human genes not related to normal genes in the human genome D. Mutations in DNA repair genes result in an increased chance of getting cancer.arrow_forward
- Explain how our understanding of the molecular basis of cancer has been used to develop new approaches to treat cancerarrow_forwardp53 iš an important tumor suppressor gene that is activated in response to a variety of stress signals. Upon activation it induces a cell cycle arrest or cell death. Hence, loss-of-function mutations in the p53 gene are found in almost every type of cancer. How do you predict loss-of-function mutations in the DNA binding domain of the p53 protein affect its function? OIt no longer will act as activator of gene expression O It no longer will act as repressor of gene expression O It no longer will act as activator or repressor of gene expression O It no longer will act as coactivator or corepressorarrow_forwardwhich of the following is peto's paradox? o despite having more cells ( and therefore more genome replications), large mammals like whales and elephants rarely get cancer. o naked mole rates rarely get cancer. o tardigrades are able to withstand radiation doses that would normally induce mautations and cause cancer in other organisms. o despite have a short lifespan ( and rapid reproduction period), rabbits rarely get cancer.arrow_forward
- Question in photoarrow_forwardResearchers were interested in the association between having a splenectomy and developing pancreatic cancer. In 2017, the researchers used medical records data from a hospital that was collected between 2000 to 2010. They identified 2,200 patients who had undergone splenectomy surgery between 2000 and 2010 and 33,000 patients who attended the hospital but did not have that form of surgery during that same period; all of the participants were cancer-free during that time. Researchers used the medical records data beginning in 2010 to follow the participants for development of cancer between 2010 and 2016 and calculated person-time at risk. The study found that 78 participants who had splenectomy surgery later developed cancer and contributed 62,175 person-years of follow up. In the non-surgery group, 12 cases of cancer occurred and they contributed 156,932 person-years of follow up. What is the source population for this study? Researchers were interested in the association…arrow_forward
arrow_back_ios
arrow_forward_ios
Recommended textbooks for you
- BiochemistryBiochemistryISBN:9781319114671Author:Lubert Stryer, Jeremy M. Berg, John L. Tymoczko, Gregory J. Gatto Jr.Publisher:W. H. FreemanLehninger Principles of BiochemistryBiochemistryISBN:9781464126116Author:David L. Nelson, Michael M. CoxPublisher:W. H. FreemanFundamentals of Biochemistry: Life at the Molecul...BiochemistryISBN:9781118918401Author:Donald Voet, Judith G. Voet, Charlotte W. PrattPublisher:WILEY
- BiochemistryBiochemistryISBN:9781305961135Author:Mary K. Campbell, Shawn O. Farrell, Owen M. McDougalPublisher:Cengage LearningBiochemistryBiochemistryISBN:9781305577206Author:Reginald H. Garrett, Charles M. GrishamPublisher:Cengage LearningFundamentals of General, Organic, and Biological ...BiochemistryISBN:9780134015187Author:John E. McMurry, David S. Ballantine, Carl A. Hoeger, Virginia E. PetersonPublisher:PEARSON
Biochemistry
Biochemistry
ISBN:9781319114671
Author:Lubert Stryer, Jeremy M. Berg, John L. Tymoczko, Gregory J. Gatto Jr.
Publisher:W. H. Freeman
Lehninger Principles of Biochemistry
Biochemistry
ISBN:9781464126116
Author:David L. Nelson, Michael M. Cox
Publisher:W. H. Freeman
Fundamentals of Biochemistry: Life at the Molecul...
Biochemistry
ISBN:9781118918401
Author:Donald Voet, Judith G. Voet, Charlotte W. Pratt
Publisher:WILEY
Biochemistry
Biochemistry
ISBN:9781305961135
Author:Mary K. Campbell, Shawn O. Farrell, Owen M. McDougal
Publisher:Cengage Learning
Biochemistry
Biochemistry
ISBN:9781305577206
Author:Reginald H. Garrett, Charles M. Grisham
Publisher:Cengage Learning
Fundamentals of General, Organic, and Biological ...
Biochemistry
ISBN:9780134015187
Author:John E. McMurry, David S. Ballantine, Carl A. Hoeger, Virginia E. Peterson
Publisher:PEARSON